Canlyniadau chwilio ar gyfer sme survival rate
Mireinio'r canlyniadau
Clirio'r cyfan5394 canlyniadau
Nid oes unrhyw ganlyniadau cyfatebol
Dewis pwnc arall neu clirio pob hidlydd.
Nid yw holl gynnwys y cyfrifia wedi'i ryddhau. Edrychwch am ddatganiadau sydd i ddod ar y calendr datganiadau. Fel arall, gallwch greu set ddata eich fun.
-
Geographic patterns of cancer survival in England for cancer of the oesophagus
1-year and 5-year age-standardised net survival (per cent) for men, women and all adults diagnosed with cancer of the oesophagus: England, NHS Region, Clinical Senate, Area Team
-
Cancer survival by NHS England Area Team: Table A
One- and five-year age-standardised net survival for cancer of the oesophagus.
-
Long-term Breast Cancer Survival - England and Wales
This presents a predicted 10-year survival (%), for women diagnosed aged 15-99, for Government Office Regions in England, and for Wales.
-
Cancer survival in England, with precision estimates, Tables 1 to 9
1-year cancer survival by Clinical Commissioning Group for all cancers combined, three cancers combined, breast, colorectal and lung. 1-, 5- and 10-year index of cancer survival estimates are also available by Sustainability and Transformation Partnerships and Cancer Alliances.
-
Cancer survival by NHS England Area Team: Table B
One and five-year age-standardised net surival for cancer of the stomach.
-
Cancer survival by NHS England Area Team: Table D
One- and five-year age-standardised net survival for cancer of the lung.
-
Cancer survival by NHS England Area Team: Table C
One- and five-year age-standardised net survival for cancer of the colon.
-
Cancer survival by NHS England Area Team: Table E
One- and five-year age-standardised net survival for cancer of the breast.
-
Cancer survival by NHS England Area Team: Table F
One- and five-year age-standardised net survival for cancer of the cervix.
-
Index of cancer survival for Clinical Commissioning Groups in England: Table 1
Number of cancer patients included in survival analyses, by calendar year of diagnosis 1997-2012 and Clinical Commissioning Groups.